BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 20339075)

  • 21. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
    Sakoda T; Kikushige Y
    Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
    Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
    J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
    Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
    Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
    Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a stroma-mediated Wnt/beta-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche.
    Kim JA; Kang YJ; Park G; Kim M; Park YO; Kim H; Leem SH; Chu IS; Lee JS; Jho EH; Oh IH
    Stem Cells; 2009 Jun; 27(6):1318-29. PubMed ID: 19489023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
    Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
    J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
    So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
    Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
    Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
    J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
    Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
    Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
    Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
    Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxycodone stimulates normal and malignant hematopoietic progenitors via opioid-receptor-independent-β-catenin activation.
    Hu N; Yu T; Chen J; Zheng S; Yan H; Duan J
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1457-1463. PubMed ID: 33268026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
    Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
    J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR.
    Chen L; Wan Y; Liu Y; Li T
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway.
    Fung TK; Gandillet A; So CW
    Curr Opin Hematol; 2012 Jul; 19(4):280-6. PubMed ID: 22525581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.
    Heuser M; Sly LM; Argiropoulos B; Kuchenbauer F; Lai C; Weng A; Leung M; Lin G; Brookes C; Fung S; Valk PJ; Delwel R; Löwenberg B; Krystal G; Humphries RK
    Blood; 2009 Nov; 114(19):3983-93. PubMed ID: 19667399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation.
    Quéré R; Karlsson G; Hertwig F; Rissler M; Lindqvist B; Fioretos T; Vandenberghe P; Slovak ML; Cammenga J; Karlsson S
    Blood; 2011 Jun; 117(22):5918-30. PubMed ID: 21471525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
    Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
    Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.
    Schürch C; Riether C; Matter MS; Tzankov A; Ochsenbein AF
    J Clin Invest; 2012 Feb; 122(2):624-38. PubMed ID: 22232214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming Wnt-β-catenin dependent anticancer therapy resistance in leukaemia stem cells.
    Perry JM; Tao F; Roy A; Lin T; He XC; Chen S; Lu X; Nemechek J; Ruan L; Yu X; Dukes D; Moran A; Pace J; Schroeder K; Zhao M; Venkatraman A; Qian P; Li Z; Hembree M; Paulson A; He Z; Xu D; Tran TH; Deshmukh P; Nguyen CT; Kasi RM; Ryan R; Broward M; Ding S; Guest E; August K; Gamis AS; Godwin A; Sittampalam GS; Weir SJ; Li L
    Nat Cell Biol; 2020 Jun; 22(6):689-700. PubMed ID: 32313104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.